Literature DB >> 3694301

The association between hypertension treatment, control, and functional status.

D S Siscovick1, D S Strogatz, S W Fletcher, B Leake, R H Brook.   

Abstract

The authors examined the relationship between hypertension treatment, control, and functional status among 356 "uncomplicated" hypertensive patients receiving care in 16 teaching hospital group practices. Antihypertensive drug therapy and blood pressure control were determined from a medical record review. Functional status (health perceptions, mental health, role, and physical functioning) was assessed with a questionnaire. After adjustment for potential confounders, hypertensive patients without drug therapy were less likely to have impairment in mental health functioning, compared with patients receiving one or more than one antihypertensive medication (9% versus 25% and 20% respectively, p less than 0.05). However, uncontrolled hypertensive patients were more likely to have role limitations than patients controlled only at the end or throughout the record review period (51% versus 39% and 36%, respectively, p less than 0.05). Patients controlled throughout the review period had the least impairment for each measure of functional status. These preliminary findings suggest that pharmacologic therapy may have a negative influence on the mental health of "uncomplicated" hypertensive patients, but that the dual goals of blood pressure control and positive functional status are not incompatible.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694301     DOI: 10.1007/bf02596367

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  19 in total

1.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

2.  Relationship of free-recall memory to hypertension in the elderly. The Iowa 65+ Rural Health Study.

Authors:  R B Wallace; J H Lemke; M C Morris; M Goodenberger; F Kohout; J V Hinrichs
Journal:  J Chronic Dis       Date:  1985

3.  General medical care and the education of internists in university hospitals. An evaluation of the teaching hospital general medicine group practice program.

Authors:  J Kosecoff; A Fink; R H Brook; A R Davies; G Goldberg; L S Linn; V A Clark; P C Salisbury
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

4.  Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

5.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

6.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

7.  Impairment of memory function by antihypertensive medication.

Authors:  S Solomon; E Hotchkiss; S M Saravay; C Bayer; P Ramsey; R S Blum
Journal:  Arch Gen Psychiatry       Date:  1983-10

8.  WAIS performance for different age groups of hypertensive and control subjects during the administration of a diuretic.

Authors:  N R Schultz; J T Dineen; M F Elias; C A Pentz; W G Wood
Journal:  J Gerontol       Date:  1979-03

9.  Hypertension labeling and well-being: alternative explanations in cross-sectional data.

Authors:  E H Wagner; D S Strogatz
Journal:  J Chronic Dis       Date:  1984

10.  Effects of mild cardiovascular and cerebrovascular disorders on serial reaction time performance.

Authors:  K C Light
Journal:  Exp Aging Res       Date:  1978-02       Impact factor: 1.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.